Dr. Lana Wahid, MD
Claim this profileDuke University Hospital
Studies Coronavirus
Studies Pneumonia
2 reported clinical trials
6 drugs studied
Affiliated Hospitals
Duke University Hospital
More about Lana Wahid, MD
Clinical Trial Related2 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 0 Active Clinical TrialsTreatments Lana Wahid, MD has experience with
- Crizanlizumab Injection
- P2Y12
- Prophylactic Heparin
- SGLT2 Inhibitor
- Theraputic Heparin
- Reparixin
Breakdown of trials Lana Wahid, MD has run
Pneumonia
Infections and Infestations
Coronavirus Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lana Wahid, MD specialize in?
Lana Wahid, MD focuses on Coronavirus and Pneumonia. In particular, much of their work with Coronavirus has involved treating patients, or patients who are undergoing treatment.
Is Lana Wahid, MD currently recruiting for clinical trials?
No, Lana Wahid, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Lana Wahid, MD has studied deeply?
Yes, Lana Wahid, MD has studied treatments such as Crizanlizumab Injection, P2Y12, prophylactic heparin.
What is the best way to schedule an appointment with Lana Wahid, MD?
Apply for one of the trials that Lana Wahid, MD is conducting.
What is the office address of Lana Wahid, MD?
The office of Lana Wahid, MD is located at: Duke University Hospital, Durham, North Carolina 27704 United States. This is the address for their practice at the Duke University Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.